Hydrocortisone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 5 EU WC, 10 KDMF, 39 NDC API, 1 VMF, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

384 FDF Dossiers, 230 FDA Orange Book, 83 Europe, 13 Canada, 6 Australia, 27 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 8 SPI Pharma, 2 Seqens, 16 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 13 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 5 Pfanstiehl, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 3 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Topical, 75 Fillers, Diluents & Binders, 57 Solubilizers, 57 Thickeners and Stabilizers, 44 Parenteral, 40 Direct Compression, 30 Coating Systems & Additives, 29 Lubricants & Glidants, 29 Disintegrants & Superdisintegrants, 28 Granulation, 27 Emulsifying Agents, 24 Controlled & Modified Release, 20 Co-Processed Excipients, 20 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 18 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Rheology Modifiers, 5 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 91 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

28 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 3 JP, 5 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 8697 / DOSAGE - TABLET;ORAL - 20MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
HYDROCORTISONE(UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)	HYDROCORTISONE	5mg

Inactive Ingredients

Ingredient Name	Major Pharmaceuticals	PD-Rx Pharmaceuticals, Inc.	West-Ward Pharmaceuticals Corp	Avera McKennan Hospital	KAISER FOUNDATION HOSPITALS	Pharmacia & Upjohn Company LLC	American Health Packaging	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	Lineage Therapeutics Inc	Par Pharmaceutical	Strides Pharma Inc.	Bryant Ranch Prepack
ANHYDROUS LACTOSE(3SY5LH9PMK)
CALCIUM STEARATE(776XM7047L)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSCARMELLOSE SODIUM(M28OL1HH48)
Lactose Monohydrate(EWQ57Q8I5X)
LACTOSE(J2B2A4N98G)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
MINERAL OIL(T5L8T28FGP)
Silicon Dioxide(ETJ7Z6XBU4)
SODIUM LAURYL SULFATE(368GB5141J)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
SODIUM STARCH GLYCOLATE TYPE B POTATO(27NA468985)
SORBIC ACID(X045WJ989B)
STARCH, CORN(O8232NY3SJ)
SUCROSE(C151H8M554)

Drug Product Composition: Hydrocortisone

Hydrocortisone

Hydrocortisone

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

29 USDMF

14 CEP/COS

6 JDMF

5 EU WC

10 KDMF

39 NDC API

1 VMF

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

384 FDF Dossiers

230 FDA Orange Book

83 Europe

13 Canada

6 Australia

27 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

CREAM;TOPICAL - 5%;1%

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc

8 SPI Pharma

2 Seqens

16 DKSH

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

13 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

5 Pfanstiehl

22 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

42 BASF

3 BioSpectra

1 Clariant

15 Corel Pharma Chem

7 DFE Pharma

6 Finar

16 Gangwal Chemicals

2 Hayashibara

3 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

31 Kerry

9 Lubrizol Life Science Health

17 Microlex e.U

3 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

33 Roquette

21 Seppic

2 Shandong Focus Biotechnology Co., Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 Valens Pharmachem

5 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Topical

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons